About Us

History

THE PRESENT

2021
  • Established Corporation in Austin, Texas U.S.
2020
  • Selected as Innovation ICON by Credit Guarantee Fund
  • Acquired domestic license for precision cooling treatment device
  • Precise cooling treatment device atopic itch and scalp seborrheic dermatitis in progress
  • Acquired Korean, American and European approvals for precision cooling treatment equipment
  • Started phase 3 clinical trial in the US for ophthalmic cooling anesthesia device (in 8 hospitals)
  • Completed 2 clinical trial in the US for ophthalmic cooling anesthesia device
2019
  • Obtained ISO 13485 certification (rapid cooling anesthesia machine, low temperature machine)
  • Acquired the license of medical device manufacturing (by Food and Drug Administration)
  • Acquired GMP certification (by Korea Testing Laboratory)
  • Completed development of precision cooling treatment equipment
  • Completed US Phase 1 clinical trial for ophthalmic cooling anesthesia device
2018
  • De Novo track confirmed by US FDA for ophthalmic cooling anesthesia
  • Completed development of cold anesthesia product
2016
  • RecensMedical corporation established